Tuesday, May 28, 2002 2:34:26 PM
NEWS
Tuesday May 28, 2:21 pm Eastern Time
Press Release
SOURCE: BioShield Technologies, Inc.
BioShield Ranks 91st Amongst 175 Listed Companies In Atlanta Journal-Constitution's Ninth Annual Best of Business for 2001
ATLANTA, May 28 /PRNewswire-FirstCall/ -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI - News) announced today that it was nominated the ninety-first (91st) position among 175 companies listed and several hundred potential candidates in the Atlanta Journal-Constitution's 9th Annual Best of Business Awards for 2001. Better known as the Georgia 100, BioShield was held in high positioning with particular regard to its rankings and growth in revenue (58.61% - rank 19); change in profit margin and ranking (50.26% - rank 42); and return on investment percentage gain and ranking (162% - ranking 14).
Tim Moses stated, "While we have been able to reach some of our growth improvement and operational cost reduction milestones, becoming part of the Georgia 100 is a great achievement for BioShield and its shareholders and we look forward to continuing this trend with a focus towards becoming a top 10 candidate in the coming years."
The Georgia 100 is an annual event that highlights the best businesses in the state of Georgia by ranking numerous public companies, both large and small, in terms of size of revenue, return on equity, return on investment, change in revenue, and change in profit margin. The annual Georgia 100 Best of Business is designed to show companies, their managers and especially their owners, shareholders, and investment community, how well they performed in the most recent fiscal year. Corporate data from official filings and other sources are analyzed by accountants in the Atlanta office of PricewaterhouseCoopers, LLP, an international accounting firm.
For more information on the 2001 Georgia 100, please visit: http://www.accessatlanta.com/ajc/business/best2002/
ABOUT BIOSHIELD
BioShield Technologies, Inc., is a Georgia-based biotechnology and antimicrobial products company. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV and eColi, on contact and can remain active for extended time periods. To date BioShield has received three US patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and stormwater.
Further information on BioShield and its line of products can be found by visiting the firm's web site at http://www.BioShield.com , or by calling 1-770-925-3653. Contact Timothy Moses.
Safe Harbor/Forward-looking Statements
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of BioShield; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of BioShield Technologies, Inc.
SOURCE: BioShield Technologies, Inc.
The best weapon against "fear" is "facts"!
Tuesday May 28, 2:21 pm Eastern Time
Press Release
SOURCE: BioShield Technologies, Inc.
BioShield Ranks 91st Amongst 175 Listed Companies In Atlanta Journal-Constitution's Ninth Annual Best of Business for 2001
ATLANTA, May 28 /PRNewswire-FirstCall/ -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI - News) announced today that it was nominated the ninety-first (91st) position among 175 companies listed and several hundred potential candidates in the Atlanta Journal-Constitution's 9th Annual Best of Business Awards for 2001. Better known as the Georgia 100, BioShield was held in high positioning with particular regard to its rankings and growth in revenue (58.61% - rank 19); change in profit margin and ranking (50.26% - rank 42); and return on investment percentage gain and ranking (162% - ranking 14).
Tim Moses stated, "While we have been able to reach some of our growth improvement and operational cost reduction milestones, becoming part of the Georgia 100 is a great achievement for BioShield and its shareholders and we look forward to continuing this trend with a focus towards becoming a top 10 candidate in the coming years."
The Georgia 100 is an annual event that highlights the best businesses in the state of Georgia by ranking numerous public companies, both large and small, in terms of size of revenue, return on equity, return on investment, change in revenue, and change in profit margin. The annual Georgia 100 Best of Business is designed to show companies, their managers and especially their owners, shareholders, and investment community, how well they performed in the most recent fiscal year. Corporate data from official filings and other sources are analyzed by accountants in the Atlanta office of PricewaterhouseCoopers, LLP, an international accounting firm.
For more information on the 2001 Georgia 100, please visit: http://www.accessatlanta.com/ajc/business/best2002/
ABOUT BIOSHIELD
BioShield Technologies, Inc., is a Georgia-based biotechnology and antimicrobial products company. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV and eColi, on contact and can remain active for extended time periods. To date BioShield has received three US patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and stormwater.
Further information on BioShield and its line of products can be found by visiting the firm's web site at http://www.BioShield.com , or by calling 1-770-925-3653. Contact Timothy Moses.
Safe Harbor/Forward-looking Statements
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of BioShield; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of BioShield Technologies, Inc.
SOURCE: BioShield Technologies, Inc.
The best weapon against "fear" is "facts"!
The best weapon against "fear" is "facts"!!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
